These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1579328)

  • 1. Effects of early postoperative chemotherapy on wound healing.
    Kolb BA; Buller RE; Connor JP; DiSaia PJ; Berman ML
    Obstet Gynecol; 1992 Jun; 79(6):988-92. PubMed ID: 1579328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.
    Morice P; Dubernard G; Rey A; Atallah D; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
    J Am Coll Surg; 2003 Dec; 197(6):955-63. PubMed ID: 14644284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Schwartz PE; Chambers JT; Makuch R
    Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
    Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
    Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL
    Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
    Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
    Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
    Moore KN; Reid MS; Fong DN; Myers TK; Landrum LM; Moxley KM; Walker JL; McMeekin DS; Mannel RS
    Gynecol Oncol; 2008 Aug; 110(2):133-9. PubMed ID: 18495221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
    Hou JY; Kelly MG; Yu H; McAlpine JN; Azodi M; Rutherford TJ; Schwartz PE
    Gynecol Oncol; 2007 Apr; 105(1):211-7. PubMed ID: 17239941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
    Aletti GD; Long HJ; Podratz KC; Cliby WA
    Gynecol Oncol; 2007 Jan; 104(1):212-6. PubMed ID: 17023033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?
    Pacelli F; Bossola M; Rosa F; Tortorelli AP; Papa V; Doglietto GB
    Clin Nutr; 2008 Jun; 27(3):398-407. PubMed ID: 18436350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis.
    Markel TA; Lou DC; Pfefferkorn M; Scherer LR; West K; Rouse T; Engum S; Ladd A; Rescorla FJ; Billmire DF
    Surgery; 2008 Oct; 144(4):540-5; discussion 545-7. PubMed ID: 18847637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer.
    Paulsen T; Kaern J; Kjaerheim K; Haldorsen T; Tropé C
    Gynecol Oncol; 2006 Sep; 102(3):447-52. PubMed ID: 16516277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
    Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
    J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.
    Ryu KS; Kim JH; Ko HS; Kim JW; Ahn WS; Park YG; Kim SJ; Lee JM
    Gynecol Oncol; 2004 Aug; 94(2):325-32. PubMed ID: 15297169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis.
    Bristow RE; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1070-6. PubMed ID: 16875720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous access device wound complications in patients undergoing paclitaxel chemotherapy for gynecologic malignancies.
    Boulay RM; Olt GJ; Podczaski ES
    Gynecol Oncol; 1998 Aug; 70(2):259-62. PubMed ID: 9740701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.